Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ120012010,00
KB10061007-0,40
PKN76,6776,71-1,41
Msft472,83472,920,41
Nokia4,6444,649-1,26
IBM276,46276,690,08
Mercedes-Benz Group AG52,2252,240,21
PFE24,5924,61,23
11.06.2025 16:05:01
Indexy online
AD Index online
select
AD Index online
 

  • 11.06.2025 15:59:43
Berkeley Grp Hld Rg (London)
Poslední obchod Změna (%) Změna (GBP) Objem obchodů (GBP)
43,18 1,22 0,52 2 939 923
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 11.06.2025
Popis společnosti

Business Summary: The Berkeley Group Holdings plc is a United Kingdom-based company engaged in building homes and neighborhoods across London, Birmingham, and the South of England. The Company and its subsidiaries are engaged in residential-led, mixed-use property development. The Company specializes in brownfield regeneration, reviving underused land to create sustainable and nature-rich places. The Company's portfolio of developments includes Sunningdale Park, Sunninghill Square, Bankside Gardens, Berkeley Place, Abbey Barn Park, Hareshill Crookham Village, Hartland Village, Knights Quarter, Hertford Locks, The Arches, The Eight Gardens, Farmstead at Tannersbrook, Hildenborough, Holborough Lakes, Foal Hurst Green, Hollyfields, Grand Union, Prince Of Wales Drive, Camden Goods Yard, South Quay Plaza, Chelsea Creek, Beaufort Park, Filmworks Ealing, Woodberry Down, Fulham Reach and others. The Company’s brands include Berkeley, St Edward, St George, St James, St Joseph, and St William.
Financial Summary: BRIEF: For the six months ended 31 October 2024, Berkeley Group Holdings PLC revenues increased 7% to L1.28B. Net income decreased 8% to L195.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Equity Earnings -Before Taxes decrease of 88% to L7.1M (income), Net operating expenses increase of 1% to L80.1M (expense).



  • Poslední aktualizace: 11.06.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerChristopher Boerner5401.04.202428.08.2018
Executive Vice President, Chief Financial Officer, Member of the Leadership TeamDavid Elkins5601.01.2019
President - RayzeBio Organization, Member of the Leadership TeamBenjamin Hickey5001.01.2024
President, Cell Therapy Organization, Member of the Leadership TeamLynelle Hoch5201.01.2023
Executive Vice President, Chief People Officer, Member of the Leadership TeamAmanda Poole5001.01.2023
Executive Vice President, Chief Digital and Technology Officer, Member of the Leadership TeamGreg Meyers5201.01.2022
Executive Vice President, General Counsel and Chief Policy OfficerCari Gallman4506.05.202501.01.2023
Executive Vice President, Chief Medical Officer, Head of Development, Member of the Leadership TeamSamit Hirawat5601.01.2019
Executive Vice President, Chief Commercialization Officer, Member of the Leadership TeamAdam Lenkowsky5226.04.202326.04.2023
Executive Vice President, Chief Research Officer, Head of Research, Member of the Leadership TeamRobert Plenge5401.01.2023